Tony P George

Summary

Affiliation: Centre for Addiction and Mental Health
Country: Canada

Publications

  1. pmc A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia
    Tony P George
    Centre for Addiction and Mental Health, Faculty of Medicine, University of Toronto, Ontario, Canada
    Biol Psychiatry 63:1092-6. 2008
  2. ncbi request reprint Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates
    Shaul Lev-Ran
    Social Aetiology of Mental Illness SAMI CIHR Training Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Addictions Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Electronic address
    Psychiatry Res 209:459-65. 2013
  3. doi request reprint Effects of cannabis use status on cognitive function, in males with schizophrenia
    Rachel A Rabin
    Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
    Psychiatry Res 206:158-65. 2013
  4. ncbi request reprint Prepulse inhibition deficits in schizophrenia are modified by smoking status
    Andrea A Woznica
    Department of Psychiatry, University of Toronto, Faculty of Medicine, 250 College Street, Toronto, Ontario, Canada
    Schizophr Res 112:86-90. 2009
  5. doi request reprint Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status
    Victoria C Wing
    Centre for Addiction and Mental Health CAMH, Schizophrenia Program Division of Addiction Psychiatry, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    Psychiatry Res 188:320-6. 2011
  6. pmc Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use
    Romina Mizrahi
    1 PET Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada 2 Faculty of Medicine, Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    Neuropsychopharmacology 39:1479-89. 2014
  7. doi request reprint Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls
    Victoria C Wing
    Department of Psychiatry, University of Toronto, Toronto, Canada
    Addict Behav 37:67-72. 2012
  8. doi request reprint Repetitive transcranial magnetic stimulation and drug addiction
    Mera S Barr
    Schizophrenia Program, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    Int Rev Psychiatry 23:454-66. 2011
  9. doi request reprint A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia
    Victoria C Wing
    Addiction Psychiatry Program, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    Ann N Y Acad Sci 1248:89-106. 2012
  10. doi request reprint Brain stimulation methods to treat tobacco addiction
    Victoria C Wing
    Biobehavioural Addictions and Concurrent Disorders Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada
    Brain Stimul 6:221-30. 2013

Collaborators

Detail Information

Publications54

  1. pmc A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia
    Tony P George
    Centre for Addiction and Mental Health, Faculty of Medicine, University of Toronto, Ontario, Canada
    Biol Psychiatry 63:1092-6. 2008
    ..We determined whether the combination of sustained-release (SR) bupropion (BUP) with the transdermal nicotine patch (TNP) was well-tolerated and superior to placebo (PLO)+TNP for smoking cessation in schizophrenia...
  2. ncbi request reprint Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates
    Shaul Lev-Ran
    Social Aetiology of Mental Illness SAMI CIHR Training Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Addictions Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Electronic address
    Psychiatry Res 209:459-65. 2013
    ..Comprehensive evaluation of patients with bipolar disorder should include a systematic assessment of CUD. ..
  3. doi request reprint Effects of cannabis use status on cognitive function, in males with schizophrenia
    Rachel A Rabin
    Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
    Psychiatry Res 206:158-65. 2013
    ..Prospective studies are needed to confirm these findings...
  4. ncbi request reprint Prepulse inhibition deficits in schizophrenia are modified by smoking status
    Andrea A Woznica
    Department of Psychiatry, University of Toronto, Faculty of Medicine, 250 College Street, Toronto, Ontario, Canada
    Schizophr Res 112:86-90. 2009
    ..However, the relationship between PPI deficits and smoking status is unclear. We examined whether smoking status modifies PPI deficits in schizophrenia...
  5. doi request reprint Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status
    Victoria C Wing
    Centre for Addiction and Mental Health CAMH, Schizophrenia Program Division of Addiction Psychiatry, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    Psychiatry Res 188:320-6. 2011
    ..Our findings suggest that smoking status and history differentially alters neuropsychological outcomes in schizophrenia compared to non-psychiatric controls, and that never-smokers may present with more severe neurocognitive impairments...
  6. pmc Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use
    Romina Mizrahi
    1 PET Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada 2 Faculty of Medicine, Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    Neuropsychopharmacology 39:1479-89. 2014
    ..Our finding does not support the cross-sensitization hypothesis, which posits greater dopaminergic reactivity to stress in CHR cannabis users, but adds to the growing body of literature showing reduced DA (stress) response in addiction. ..
  7. doi request reprint Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls
    Victoria C Wing
    Department of Psychiatry, University of Toronto, Toronto, Canada
    Addict Behav 37:67-72. 2012
    ..This study examined the relationship between cigarette smoking and delay discounting in schizophrenia and control participants...
  8. doi request reprint Repetitive transcranial magnetic stimulation and drug addiction
    Mera S Barr
    Schizophrenia Program, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    Int Rev Psychiatry 23:454-66. 2011
    ..Although work in this area is limited, this review indicates that rTMS is a promising modality for treating drug addiction...
  9. doi request reprint A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia
    Victoria C Wing
    Addiction Psychiatry Program, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    Ann N Y Acad Sci 1248:89-106. 2012
    ..In addition, suggestions for future lines of research to better understand reasons for the comorbidity of nicotine addiction in schizophrenia are discussed...
  10. doi request reprint Brain stimulation methods to treat tobacco addiction
    Victoria C Wing
    Biobehavioural Addictions and Concurrent Disorders Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada
    Brain Stimul 6:221-30. 2013
    ..Brain stimulation methods are gaining increasing interest as possible addiction therapeutics...
  11. pmc Elevation of dopamine induced by cigarette smoking: novel insights from a [(11)C]-(+)-PHNO PET study in humans
    Bernard Le Foll
    1 Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada 2 Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments, Centre for Addiction and Mental Health, Toronto, ON, Canada 3 Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada 4 Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada 5 Department of Pharmacology, University of Toronto, Toronto, ON, Canada 6 Department of Psychiatry, Division of Brain and Therapeutics, University of Toronto, Toronto, ON, Canada 7 Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada
    Neuropsychopharmacology 39:415-24. 2014
    ..We propose that due to the robust effect of smoking on [(11)C]-(+)-PHNO binding, this radiotracer represents an ideal translational tool to investigate novel therapeutic strategies targeting DA transmission. ..
  12. pmc Heightened D(3) dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [(11)C]-(+)-PHNO
    Doris E Payer
    1 Addiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, ON, Canada 2 Research Imaging Centre and Vivian M Rakoff PET Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada
    Neuropsychopharmacology 39:311-8. 2014
    ..D3 upregulation is emerging as a biomarker in preclinical models of addiction, and human PET studies of this receptor system can help guide novel pharmacological strategies for treatment. ..
  13. pmc Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status
    Rachel A Rabin
    Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Schizophr Res 114:91-7. 2009
    ..However, little is known about how smoking status modulates the relationships between neurocognitive measures in schizophrenia and healthy control subjects...
  14. pmc A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities
    Taryn G Moss
    Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    Am J Addict 19:293-311. 2010
    ..Finally, questions for further research in this field are delineated. This Tobacco Reconceptualization in Psychiatry is long overdue, given the clear and compelling benefits of tobacco-free environments in psychiatric institutions...
  15. doi request reprint Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking
    Ingrid Bacher
    Vivian M Rakoff PET Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, 250 College St, Toronto, ON, Canada
    Arch Gen Psychiatry 68:817-26. 2011
    ..Dysphoria during cigarette withdrawal predicts relapse. It is unknown whether MAO-A binding increases during early cigarette withdrawal...
  16. doi request reprint Cannabis use and cannabis use disorders among individuals with mental illness
    Shaul Lev-Ran
    Social Aetiology of Mental Illness CIHR Training Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Compr Psychiatry 54:589-98. 2013
    ..However, this subject has not been sufficiently investigated, particularly given limitations in diagnostic tools used and lack of data pertaining to frequency of cannabis used...
  17. pmc Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO
    Romina Mizrahi
    Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada
    Neuropsychopharmacology 38:673-82. 2013
    ..566, p=0.044), with no effect in any other brain region. In conclusion, despite an increase in striatal BP(ND) observed during the control task, chronic cannabis use is not associated with alterations in stress-induced DA release...
  18. doi request reprint The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis
    Rachel A Rabin
    The Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
    Schizophr Res 128:111-6. 2011
    ..Explanations for these findings are discussed and suggestions for future research in this area are recommended...
  19. doi request reprint Individualized smoking cessation treatment in an outpatient setting: Predictors of outcome in a sample with psychiatric and addictions co-morbidity
    Peter Selby
    Addictions Program and Nicotine Dependence Clinic, Centre for Addiction and Mental Health, Toronto, ON, Canada M5S 2S1
    Addict Behav 35:811-7. 2010
    ..However, few studies have compared patients with schizophrenia or schizoaffective disorders to patients with other psychiatric diagnoses without psychosis, addressing ability to quit and differences in treatment characteristics...
  20. pmc Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems
    Kristen M Mackowick
    The Institute of Medical Sciences IMS, University of Toronto, Toronto, Ontario Canada Schizophrenia Division, Centre for Addiction and Mental Health CAMH, University of Toronto, Toronto, Ontario Canada
    Prog Neuropsychopharmacol Biol Psychiatry 52:79-85. 2014
    ..These positive effects on neurocognition appear to be more pronounced in smokers with schizophrenia, and may be an important mechanism that explains the co-morbidity of schizophrenia and tobacco dependence. ..
  21. doi request reprint Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls
    Dominique Morisano
    Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Am J Addict 22:46-53. 2013
    ..These disorders are also associated with neurocognitive impairments. Cigarette smoking is associated with improved cognition in SZ. The effects of smoking on cognition in BD and MDD are less well studied...
  22. pmc Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study
    Isabelle Boileau
    Addiction Imaging Research Group, Vivian M Rakoff PET Imaging Centre, Human Brain Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada M5T 1R8
    J Neurosci 32:1353-9. 2012
    ..Pharmacological studies are needed to establish whether normalization of D3 receptor function could reduce vulnerability to relapse in stimulant abuse...
  23. ncbi request reprint Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders
    Dominique Morisano
    Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ontario
    Can J Psychiatry 54:356-67. 2009
    ....
  24. ncbi request reprint Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders
    Mera S Barr
    Schizophrenia Program, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Ontario, Canada
    Curr Drug Abuse Rev 1:328-39. 2008
    ..Further work is needed to enhance our understanding of the altered neurophysiology in SUDs as well as the ways in which rTMS treatment can be directed to optimize treatment...
  25. doi request reprint Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
    Ingrid Bacher
    University of Toronto, Department of Psychiatry, Faculty of Medicine, Toronto, Canada
    Expert Opin Pharmacother 10:2709-21. 2009
    ..These areas of investigation for mecamylamine are reviewed and recommendations for future research directions are proposed...
  26. doi request reprint Pharmacogenetics of alcohol, nicotine and drug addiction treatments
    Jessica E Sturgess
    Centre for Addiction and Mental Health, Pharmacogenetics Research Clinic, 250 College Street, Toronto, Ontario, Canada
    Addict Biol 16:357-76. 2011
    ....
  27. pmc Treatment of tobacco dependence: integrating recent progress into practice
    Bernard Le Foll
    Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ont
    CMAJ 177:1373-80. 2007
    ..Specifically, we discuss the use of nicotine replacement therapy, bupropion and varenicline in primary care settings...
  28. pmc Smoking cue reactivity in adult smokers with and without depression: a pilot study
    Andrea H Weinberger
    Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Am J Addict 21:136-44. 2012
    ..The association between depression symptoms and smoking urges was not significant in the Brief Deprivation Condition. Smoking cue reactivity may be a useful procedure for studying aspects of smoking behavior in adults with depression...
  29. pmc Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial
    Benjamin A Toll
    Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06511, USA
    Psychol Addict Behav 21:534-44. 2007
    ..These data suggest that gain-framed messages may be more persuasive than loss-framed messages in promoting early success in smoking cessation for participants who are engaged in treatment...
  30. doi request reprint Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia
    Kristi A Sacco
    Schizophr Res 103:326-7. 2008
  31. ncbi request reprint Acute tryptophan depletion in schizophrenic patients treated with clozapine
    Tony P George
    Arch Gen Psychiatry 59:291-2. 2002
  32. ncbi request reprint A placebo controlled trial of bupropion for smoking cessation in schizophrenia
    Tony P George
    Program for Research in Smokers with Mental Illness and Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Biol Psychiatry 52:53-61. 2002
    ..We compared sustained-release (SR) bupropion with placebo for smoking cessation in patients with schizophrenic disorders. We also examined how antipsychotic class predicts smoking cessation outcomes with bupropion...
  33. ncbi request reprint Smoking cessation and panic attacks: a report of 2 cases
    Jennifer C Vessicchio
    J Clin Psychiatry 63:594-5. 2002
  34. ncbi request reprint Current pharmacological treatments for nicotine dependence
    Tony P George
    Center for Nicotine and Tobacco Use Research at Yale, Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, Room S 109, SAC, New Haven, CT 06519, USA
    Trends Pharmacol Sci 25:42-8. 2004
    ..Several existing medications are being tested as treatments for nicotine dependence and novel investigational agents are under development as effective treatments for nicotine dependence in the 'hard to treat' tobacco user...
  35. ncbi request reprint Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia
    Sara L Dolan
    Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, 34 Park Street, Rm S 109, Substance Abuse Center, New Haven, CT 06519, USA
    Schizophr Res 70:263-75. 2004
    ..These preliminary data suggest that in schizophrenics, neuropsychological deficits are associated with smoking cessation treatment failure...
  36. ncbi request reprint Non-nicotine pharmacotherapies for nicotine dependence
    Melissa M Dudas
    Program for Research in Smokers with Mental Illness PRISM, Connecticut Mental Health Center, New Haven, CT, USA
    Essent Psychopharmacol 6:158-72. 2005
    ..Studies summarizing the effectiveness (or lack thereof) of other (off-label) agents, such as tricyclic antidepressants, MAO-Inhibitors, SSRIs, and clonidine, are cited...
  37. ncbi request reprint Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Arch Gen Psychiatry 62:649-59. 2005
    ..Cigarette smoking rates in schizophrenia are higher than in the general population...
  38. ncbi request reprint A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms
    Tony P George
    Program for Research in Smokers with Mental Illness PRISM, Department of Psychiatry, Yale University School of Medicine, Substance Abuse Center, Connecticut Mental Health Center, New Haven, CT 06519, USA
    Schizophr Res 87:307-15. 2006
    ..We evaluated the effects of cigarette smoking on PPI deficits in schizophrenia, and the role of nicotinic acetylcholine receptors (nAChRs) in mediating cigarette smoking-related PPI enhancement...
  39. ncbi request reprint Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia
    Andrea H Weinberger
    Program for Research on Smokers with Mental Illness, Yale University School of Medicine, New Haven, CT 06511, USA
    Drug Alcohol Depend 86:278-82. 2007
    ..65 versus 0.79), and TQSU Factor 2 (0.69 versus 0.81), but did not differ between diagnostic groups for M-NWS (0.58 versus 0.64). Our findings suggest that these measures may be reliable for use in smokers with schizophrenia...
  40. pmc Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia
    Andrea H Weinberger
    Program for Research on Smokers with Mental Illness PRISM, Yale University School of Medicine, Department of Psychiatry, 34 Park Street, New Haven, CT 06519, USA
    Schizophr Res 91:217-25. 2007
    ....
  41. ncbi request reprint Adverse childhood experiences, smoking and mental illness in adulthood: a preliminary study
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness PRISM, Connecticut Mental Health Center, Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Ann Clin Psychiatry 19:89-97. 2007
    ..This study was designed to examine effects of ACE on the expression of smoking behavior and mental illness in adulthood...
  42. pmc Effects of acute tobacco abstinence in adolescent smokers compared with nonsmokers
    Anne E Smith
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    J Adolesc Health 43:46-54. 2008
    ..This study aimed to prospectively document tobacco abstinence-induced changes during the first 48 hours of abstinence in adolescent smokers compared with nonsmokers, to distinguish effects distinct from typical adolescent lability...
  43. ncbi request reprint The potential of dopamine agonists in drug addiction
    Thomas R Kosten
    Yale University School of Medicine, VA Connecticut Healthcare System, Department of Psychiatry, West Haven, CT 06516, USA
    Expert Opin Investig Drugs 11:491-9. 2002
    ..Animal studies also suggest that tailoring treatment to subgroups of patients based on genotype may improve responses...
  44. ncbi request reprint Survey of clinician attitudes toward smoking cessation for psychiatric and substance abusing clients
    Andrea H Weinberger
    Program for Research in Smokers with Mental Illness PRISM, Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
    J Addict Dis 27:55-63. 2008
    ..We suggest that mental health clinicians can be instrumental in providing information, encouragement, and opportunities for their patients to attempt smoking cessation...
  45. doi request reprint Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study
    Tony P George
    Division of Substance Abuse, Department of Psychiatry, Program for Research in Smokers with Mental Illness, Yale University School of Medicine, New Haven, CT, USA
    J Clin Psychopharmacol 28:340-4. 2008
    ..We compared the nicotinic antagonist, mecamylamine hydrochloride (MEC), with placebo as an augmentation strategy for patients with MDD who were refractory to selective serotonin reuptake inhibitor (SSRI) treatment...
  46. ncbi request reprint A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation
    Tony P George
    Program for Research in Smokers with Mental Illness PRISM, New Haven, Connecticut 06519, USA
    Biol Psychiatry 53:136-43. 2003
    ....
  47. ncbi request reprint Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study
    Gerardo Gonzalez
    Department of Psychiatry, Yale University School of Medicine, West Haven, CT, USA
    Addiction 98:1625-32. 2003
    ..We sought to evaluate the safety and efficacy of the GABAergic agent tiagabine in reducing cocaine use among methadone-treated patients...
  48. ncbi request reprint Neurocognitive performance among alcohol dependent men with and without physical violence toward their partners: a preliminary report
    Caroline J Easton
    Department of Psychiatry, Division of Substance Abuse, Yale University School of Medicine SATU, New Haven, Connecticut 06511, USA
    Am J Drug Alcohol Abuse 34:29-37. 2008
    ..The authors examined neurocognitive performance among treatment-seeking alcohol dependent men with (IPV+) and without reported physical violence (IPV-)...
  49. ncbi request reprint Characteristics of tobacco-smoking problem gamblers calling a gambling helpline
    Marc N Potenza
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
    Am J Addict 13:471-93. 2004
    ..The high proportion of callers reporting daily tobacco smoking highlights the need for enhanced smoking cessation efforts in problem gamblers...
  50. ncbi request reprint Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist
    Margaret A Fonder
    Program for Research in Smokers with Mental Illness PRISM, Connecticut Mental Health Center, and Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Biol Psychiatry 57:802-8. 2005
    ....
  51. ncbi request reprint Treatment of patients with substance use disorders, second edition. American Psychiatric Association
    Herbert D Kleber
    Am J Psychiatry 164:5-123. 2007
  52. ncbi request reprint Cigarette smoking in Chinese male inpatients with schizophrenia: a cross-sectional analysis
    Yi lang Tang
    Beijing Anding Hospital, Capital University of Medical Sciences, Beijing, China
    J Psychiatr Res 41:43-8. 2007
    ..Accordingly, cigarette smoking may be associated with certain clinical features in schizophrenic patients, and should be carefully screened for when making treatment and rehabilitation plans...
  53. ncbi request reprint Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist
    Kristi A Sacco
    Program for Research in Smokers with Mental Illness PRISM, Yale University School of Medicine, New Haven, CT 06519, USA
    Schizophr Res 85:213-21. 2006
    ....
  54. ncbi request reprint Effects of smoking abstinence on visuospatial working memory function in schizophrenia
    Tony P George
    Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
    Neuropsychopharmacology 26:75-85. 2002
    ..These results suggest that smoking abstinence differentially alters VSWM in schizophrenic vs. control smokers, and that cigarette smoking has beneficial effects on VSWM in schizophrenic, but not control, smokers...